These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14501009)

  • 1. Immunological approach for the treatment of Alzheimer's disease.
    Solomon B
    J Mol Neurosci; 2003; 20(3):283-6. PubMed ID: 14501009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
    Solomon B
    DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhang J; Wu X; Qin C; Qi J; Ma S; Zhang H; Kong Q; Chen D; Ba D; He W
    Neurobiol Dis; 2003 Dec; 14(3):365-79. PubMed ID: 14678754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.
    Wang J; Hara H; Makifuchi T; Tabira T
    J Alzheimers Dis; 2008 Jun; 14(2):161-73. PubMed ID: 18560128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological approaches as therapy for Alzheimer's disease.
    Solomon B
    Expert Opin Biol Ther; 2002 Dec; 2(8):907-17. PubMed ID: 12517269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination.
    Solomon B
    J Alzheimers Dis; 2006; 9(3 Suppl):433-8. PubMed ID: 16914882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and immunotherapy.
    Solomon B
    Curr Alzheimer Res; 2004 Aug; 1(3):149-63. PubMed ID: 15975063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
    Wang CM; Devries S; Camboni M; Glass M; Martin PT
    Neurobiol Dis; 2010 Sep; 39(3):409-22. PubMed ID: 20493257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.
    Sambamurti K; Pappolla MA; Jagannatha Rao KS
    J Alzheimers Dis; 2008 Jun; 14(2):175-7. PubMed ID: 18663823
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
    Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
    J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
    Levites Y; Jansen K; Smithson LA; Dakin R; Holloway VM; Das P; Golde TE
    J Neurosci; 2006 Nov; 26(46):11923-8. PubMed ID: 17108166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
    PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
    Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
    J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.
    Fukuchi K; Accavitti-Loper MA; Kim HD; Tahara K; Cao Y; Lewis TL; Caughey RC; Kim H; Lalonde R
    Biochem Biophys Res Commun; 2006 May; 344(1):79-86. PubMed ID: 16630540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
    J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.
    Fukuchi K; Tahara K; Kim HD; Maxwell JA; Lewis TL; Accavitti-Loper MA; Kim H; Ponnazhagan S; Lalonde R
    Neurobiol Dis; 2006 Sep; 23(3):502-11. PubMed ID: 16766200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Abeta immunotherapy approaches for Alzheimer's disease.
    Town T
    CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):114-27. PubMed ID: 19355932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.